Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian equity markets shed gains
Fri, 1 Nov 01:30 pm

The Indian markets have shed gains during the post noon trading session. Sectoral indices are trading mixed. While stocks from realty and auto are witnessing maximum buying interest stocks from consumer durables and oil and gas are at the receiving end.

BSE-Sensex is up by 10 points and NSE-Nifty is trading up by 4 points. While BSE Mid Cap is trading up by 0.93%, BSE Small Cap index is trading up by 0.62%. The rupee is trading at 61.88 to the US dollar.

Most of the Indian pharma stocks are trading in green, with Dishman pharma and Panacea biotech being the leading gainers. Glenmark pharmaceuticals declared September quarter results. The company has reported topline growth of 16.6% YoY for the current quarter. The growth was led by both specialty and generics segment. Most of the export markets witnessed good growth; however company witnessed challenges in some emerging markets. The domestic formulations too witnessed better growth compared to the other pharma players. On the margins front, company's EBITDA margins remained flat, largely due to increase in the R&D expenses. The bottom line of the company was down by 1.6% YoY, due to surge in taxes and depreciation expenses. Glenmark's stock is currently trading down by 3.2%.

All the public sector banks are trading in the green with Corporation bank and Indian Bank being the biggest gainers. As per a leading financial daily, State Bank of India (SBI) has raised interest rates on fixed deposit by 0.2% on select maturity. Post revision, term deposits less than Rs 10 m with 180-210 days maturity will offer interest rate of 7% as against 6.8% earlier. There is no change in the interest rates for term deposits of the other maturities. SBI's stock is currently trading up by 3.7%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets shed gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.